Evidence map›Paper›PMID 35982091›Full record

ArticleNPJ Parkinson's disease2022

Estrogen-related receptor gamma regulates mitochondrial and synaptic genes and modulates vulnerability to synucleinopathy.

S N Fox, L J McMeekin, C H Savage, K L Joyce, S M Boas, M S Simmons, C B Farmer, J Ryan, L Pereboeva, K Becker and 8 more

Open access · goldAbstract read
In one paragraph

Article in NPJ Parkinson's disease, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
3.7field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 33 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. RNA Sequencing in AdultbioRxiv : the preprint server for biology · 2026
    Article
  7. Article
  8. Structural Pharmacology of Estrogen-Related Receptors.ACS pharmacology & translational science · 2026
    Review
  9. Article
  10. Selective loss and transcriptional reprogramming of Nox4The journal of headache and pain · 2025
    Article
  11. The connection between autophagy and Alzheimer's disease.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2025
    Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 5 institutions in 2 countries.

S N FoxNeuroscience Department, Drug Discovery Division, Southern Research, Birmingham, AL, 35205, USA.ORCID http://orcid.org/0000-0003-2170-8342
L J McMeekinNeuroscience Department, Drug Discovery Division, Southern Research, Birmingham, AL, 35205, USA.
C H SavageNeuroscience Department, Drug Discovery Division, Southern Research, Birmingham, AL, 35205, USA.
K L JoyceNeuroscience Department, Drug Discovery Division, Southern Research, Birmingham, AL, 35205, USA.
S M BoasNeuroscience Department, Drug Discovery Division, Southern Research, Birmingham, AL, 35205, USA.ORCID http://orcid.org/0000-0003-3572-7819
M S SimmonsDepartment of Cell, Developmental and Integrative Biology, University of Alabama at Birmingham, Birmingham, AL, 35294, USA.
C B FarmerDepartment of Psychiatry and Behavioral Neurobiology, University of Alabama at Birmingham, Birmingham, AL, 35294, USA.
J RyanNeuroInitiative, LLC, Jacksonville, FL, 32207, USA.ORCID http://orcid.org/0000-0002-6194-5855
L PereboevaDepartment of Pediatrics, Infectious Disease, Neuroscience Vector and Virus Core, University of Alabama at Birmingham, Birmingham, AL, 35223, USA.
K BeckerDepartment of Neurodegenerative Science, Van Andel Institute, Grand Rapids, MI, 49503, USA.
J AuwerxSwiss Federal Institute of Technology Lausanne, Lausanne, Switzerland.
S SudarshanDepartment of Urology, University of Alabama at Birmingham, Birmingham, AL, 35294, USA.
J MaDepartment of Neurodegenerative Science, Van Andel Institute, Grand Rapids, MI, 49503, USA.
A LeeNeuroInitiative, LLC, Jacksonville, FL, 32207, USA.ORCID http://orcid.org/0000-0002-1510-6831
R C RobertsDepartment of Psychiatry and Behavioral Neurobiology, University of Alabama at Birmingham, Birmingham, AL, 35294, USA.
D K CrossmanDepartment of Genetics, University of Alabama at Birmingham, Birmingham, AL, 35294, USA.ORCID http://orcid.org/0000-0002-0981-169X
A KralliDepartment of Physiology, Johns Hopkins University School of Medicine, Baltimore, MD, 21205, USA.
R M CowellNeuroscience Department, Drug Discovery Division, Southern Research, Birmingham, AL, 35205, USA. rcowell@southernresearch.org.ORCID http://orcid.org/0000-0001-5814-9412
Southern Research Institute · USUniversity of Alabama at Birmingham · USVan Andel Institute · USÉcole Polytechnique Fédérale de Lausanne · CHJohns Hopkins University · US

Funding

UAB Neuroscience Core CenterP30NS047466 · NINDS · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI STANDAERT, DAVID G. · 2005 to 2019
$8.5M
Transcriptional regulation of metabolism in neuronsR01NS101958 · NINDS · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI COWELL, RITA MARIE · 2017 to 2021
$2.1M
UAB Training Program In NeuroscienceT32NS095775 · NINDS · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI Erik D Roberson · 2017 to 2026
$1.6M
Omic profiling of vulnerable synapses in age-related neurodegenerationF99AG068428 · NIA · SOUTHERN RESEARCH INSTITUTE · PI FOX, STEPHANIE N · 2020 to 2021
$93k
Michael J. Fox Foundation for Parkinson's Research (Michael J. Fox Foundation) Target Validation Award #10758NIA NIH HHS F99 AG068428NINDS NIH HHS P30 NS047466NINDS NIH HHS R01 NS101958NINDS NIH HHS T32 NS095775University of Alabama at Birmingham (UAB) 5 T32NS095775U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke (NINDS) 5 R01 NS101958U.S. Department of Health & Human Services | NIH | National Institute on Aging (U.S. National Institute on Aging) 5 F99AG068428
6 · The paper itself

Abstract

Many studies implicate mitochondrial dysfunction as a key contributor to cell loss in Parkinson disease (PD). Previous analyses of dopaminergic (DAergic) neurons from patients with Lewy-body pathology revealed a deficiency in nuclear-encoded genes for mitochondrial respiration, many of which are targets for the transcription factor estrogen-related receptor gamma (Esrrg/ERRγ). We demonstrate that deletion of ERRγ from DAergic neurons in adult mice was sufficient to cause a levodopa-responsive PD-like phenotype with reductions in mitochondrial gene expression and number, that partial deficiency of ERRγ hastens synuclein-mediated toxicity, and that ERRγ overexpression reduces inclusion load and delays synuclein-mediated cell loss. While ERRγ deletion did not fully recapitulate the transcriptional alterations observed in postmortem tissue, it caused reductions in genes involved in synaptic and mitochondrial function and autophagy. Altogether, these experiments suggest that ERRγ-deficient mice could provide a model for understanding the regulation of transcription in DAergic neurons and that amplifying ERRγ-mediated transcriptional programs should be considered as a strategy to promote DAergic maintenance in PD.

Identifiers

PMID35982091
PMCPMC9388660
OpenAlexW4293828335

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.